This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter: revenue up 11.6%, net profit up 12.1%; dividend Rs 3.50
DABUR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended September 30, 2026: revenue from operations was Rs 3,563.07 crore, up 11.6% from Rs 3,191.32 crore a year earlier; profit after tax was Rs 498.57 crore, up 12.1% from Rs 444.79 crore. Operating margin was 17.75% versus 18.43%. Interim dividend: Rs 3.50 per share, Rs 620.88 crore, payable from November 25, 2026. Consolidated half-year operating cash flow: Rs 709.37 crore. Consolidated debt-to-equity was 0.13.
Revenue and profit rose, but margin narrowed. The interim dividend aids returns; positive cash flow and low leverage support financial strength.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3,563 Cr | ₹3,191 Cr | +11.6% |
| Operating profit | ₹473.9 Cr | ₹433.0 Cr | +9.5% |
| Profit after tax | ₹498.6 Cr | ₹444.8 Cr | +12.1% |
| EBITDA margin | 17.8% | 18.4% | −0.7 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.